GRANULES vs NECLIFE: Stock Comparison

GRANULES INDIA vs NECTAR LIFESCIENCESUpdated 11 Sept 26, 4:08 PM ISTNSE & company filings

GRANULES INDIA is the larger company by market capitalisation. GRANULES INDIA shows a higher ROE, a higher dividend yield and faster revenue growth, while NECTAR LIFESCIENCES shows a lower P/E and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GRANULES leads 9; NECLIFE leads 3 of 12

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GRANULESNECLIFE

Valuation lens

What price are you paying?

Market CapContext only
₹22,541 Cr
₹228 Cr
P/E RatioNECLIFE has the lower reading
33.73x
0x
P/B RatioNECLIFE has the lower reading
4.43x
0.4x
EPSGRANULES has the higher reading
₹7.26
₹-0.68
Book ValueContext only
₹205.21
₹29.97
Dividend YieldGRANULES has the higher reading
0.19%
0%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
GRANULES is the larger company
₹22,541 Cr vs ₹228 Cr
P/E Ratio
NECLIFE has a lower P/E
0x vs 33.73x
P/B Ratio
NECLIFE has a lower P/B
0.4x vs 4.43x
EPS
GRANULES has higher earnings per share
₹7.26 vs ₹-0.68
Dividend Yield
GRANULES has a higher dividend yield
0.19% vs 0%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs -3.41%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs 0%
Qtr Sales Growth
GRANULES has stronger quarterly sales growth
84.16% vs 0%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESNECLIFE
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESNECLIFE
Live Price₹909.3₹11.5
Day Change1.12%-3.6%
Volume78.51 L1.11 L
52-Week High₹910₹21.4
52-Week Low₹510.55₹9.3
Distance from 52W High-0.08%-46.26%

Valuation

MetricGRANULESNECLIFE
Market Cap₹22,541 Cr₹228 Cr
P/E Ratio33.73x0x
P/B Ratio4.43x0.4x
EPS₹7.26₹-0.68
Book Value₹205.21₹29.97
Dividend Yield0.19%0%

Growth

MetricGRANULESNECLIFE
Revenue Growth (TTM YoY)22.8%-3.41%
EPS Growth (TTM YoY)31.3%0%
Qtr Sales Growth84.16%0%
Qtr Profit Growth150.83%16.44%

Profitability & Leverage

MetricGRANULESNECLIFE
ROE9.11%-9.85%
ROCE9.07%-8.89%
Net Margin11.15%-11.28%
Operating Margin17.19%
Debt to Equity0.17x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricGRANULESNECLIFE
Promoter Holding37.67%51.84%
FII Holding17.5% 2.19 pp0.5% 0.1 pp
DII Holding16.11% 0.9 pp3.74% 0.27 pp
Public Holding28.38% 1.28 pp43.89% 0.37 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: GRANULES INDIA and NECTAR LIFESCIENCES.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.